Results 171 to 180 of about 133,468 (309)
A febrile papulovesicular rash in a patient with pyoderma gangrenosum
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Anika Rajput Khokhar +5 more
wiley +1 more source
In this study, we characterize a distinct subpopulation of undifferentiated invariant natural killer T (iNKT) cells in the peripheral blood of healthy adults, which are characterized by CD38 expression in a resting state. This CD38+ subset closely resembles iNKT cells from cord blood and thymus, exhibiting a unique cytokine profile and alterations in ...
Christopher Menne +13 more
wiley +1 more source
Scoping Review of Sexual and Gender Minority Health Research in Ireland
ABSTRACT Aim To map existing sexual and gender minority (SGM) health research in Ireland, identify gaps in literature and outline priorities for future research and healthcare. SGM is an umbrella term that includes people who identify as lesbian, gay, bisexual, transgender, queer or intersex and is sometimes abbreviated as LGBTQI+.
John P. Gilmore +7 more
wiley +1 more source
Long-term immunogenicity of hepatitis B vaccine and impact of a booster dose on health care students [PDF]
Behzad Bijani +4 more
openalex +1 more source
In this Phase III study, secukinumab demonstrated sustained efficacy and a favourable safety profile in paediatric patients with chronic severe plaque psoriasis over a treatment period of 236 weeks. Abstract Background Plaque psoriasis, a chronic inflammatory disease, affects up to 2.1% of the global paediatric population.
Andrzej Kaszuba +11 more
wiley +1 more source
Do we need better hepatitis B vaccines? [PDF]
Gerlich WH.
europepmc +1 more source
Chip Shots: Association Between the State Children's Health Insurance Programs and Immunization Coverage and Delivery [PDF]
By age two a child who is up to date for immunizations will have received up to 19 shots delivered over eight visits at a market cost of $525 dollars for the vaccines alone, a far more expensive and demanding regimen that the 8 shots received in 1987. In
Andrew Racine, Ted Joyce
core
French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025
New 2025 French guidelines update psoriasis management with revised algorithms integrating recent systemic therapies. They recommend methotrexate, adalimumab or ustekinumab as first‐line treatments and provide guidance for special psoriasis forms, comorbidities, pregnancy and long‐term management.
Marie Masson Regnault +51 more
wiley +1 more source

